Pulmonary hypertension in chronic dialysis patients with arteriovenous fistula: pathogenesis and therapeutic prospective
暂无分享,去创建一个
M. Yigla | S. Reisner | F. Nakhoul | Z. Abassi | E. Khankin
[1] T. Fleming,et al. Sildenafil citrate therapy for pulmonary arterial hypertension. , 2005, The New England journal of medicine.
[2] L. Rubin,et al. Current treatment strategies for pulmonary arterial hypertension , 2005, Journal of internal medicine.
[3] E. Bossone,et al. Pulmonary arterial hypertension: the key role of echocardiography. , 2005, Chest.
[4] K. Wissing,et al. Regression of Left Ventricular Hypertrophy After Arteriovenous Fistula Closure in Renal Transplant Recipients: A Long‐Term Follow‐Up , 2004, American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons.
[5] J. Loscalzo,et al. Pulmonary arterial hypertension. , 2004, Annals of medicine.
[6] M. Humbert,et al. Treatment of pulmonary arterial hypertension. , 2004, The New England journal of medicine.
[7] J. Krishnan,et al. Pulmonary hypertension as a risk factor for death in patients with sickle cell disease. , 2004, The New England journal of medicine.
[8] M. Yigla,et al. The pathogenesis of pulmonary hypertension in haemodialysis patients via arterio-venous access. , 2004, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.
[9] K. Budde,et al. Treatment of secondary pulmonary hypertension with bosentan and its pharmacokinetic monitoring in ESRD. , 2004, American journal of kidney diseases : the official journal of the National Kidney Foundation.
[10] A. Elhendy,et al. Pulmonary hypertension in patients with chronic renal failure: role of parathyroid hormone and pulmonary artery calcifications. , 2003, Chest.
[11] M. Yigla,et al. Pulmonary hypertension in patients with end-stage renal disease. , 2003, Chest.
[12] N. Morrell,et al. Molecular and cellular basis of pulmonary vascular remodeling in pulmonary hypertension. , 2002, Progress in cardiovascular diseases.
[13] A. Sassano,et al. The impact of arteriovenous fistula formation on central hemodynamic pressures in chronic renal failure patients: a prospective study. , 2002, American journal of kidney diseases : the official journal of the National Kidney Foundation.
[14] J. Donohoe,et al. Reversal of pulmonary hypertension after ligation of a brachiocephalic arteriovenous fistula. , 2002, American journal of kidney diseases : the official journal of the National Kidney Foundation.
[15] M. Mariani,et al. Association between high-normal albuminuria and risk factors for cardiovascular and renal disease in essential hypertensive men. , 2002, American journal of kidney diseases : the official journal of the National Kidney Foundation.
[16] R. Barst,et al. Bosentan therapy for pulmonary arterial hypertension. , 2002, The New England journal of medicine.
[17] N. Vaziri. Effect of chronic renal failure on nitric oxide metabolism. , 2001, American journal of kidney diseases : the official journal of the National Kidney Foundation.
[18] K. Hruska,et al. Pathophysiological mechanisms of vascular calcification in end-stage renal disease. , 2001, Kidney international.
[19] S. Rich,et al. Primary pulmonary hypertension: a vascular biology and translational research "Work in progress". , 2000, Circulation.
[20] S. Oparil,et al. Endothelial dysfunction in the pulmonary vascular bed. , 2000, The American journal of the medical sciences.
[21] M. Yigla,et al. Background diseases in 671 patients with moderate to severe pulmonary hypertension. , 2000, The Israel Medical Association journal : IMAJ.
[22] J. McMurray,et al. Impaired endothelium-dependent vasodilatation in uraemia. , 2000, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.
[23] A. Jardine,et al. The vascular endothelium in chronic renal failure. , 2000, Journal of nephrology.
[24] M. Landray,et al. Abnormalities of endothelial function in patients with predialysis renal failure , 2000, Heart.
[25] M. Hijmering,et al. Nitric oxide production is reduced in patients with chronic renal failure. , 1999, Arteriosclerosis, thrombosis, and vascular biology.
[26] P. R. Young,et al. High-output cardiac failure secondary to a brachiocephalic arteriovenous hemodialysis fistula: two cases. , 1998, The American surgeon.
[27] D. Brooks. SYMPOSIUM Experimental Biology 1995 Endothelin Receptors: Role in Renal Function and Dysfunction ROLE OF ENDOTHELIN IN RENAL FUNCTION AND DYSFUNCTION , 1996, Clinical and experimental pharmacology & physiology.
[28] A Giaid,et al. Reduced expression of endothelial nitric oxide synthase in the lungs of patients with pulmonary hypertension. , 1995, The New England journal of medicine.
[29] H. Okura,et al. High-output heart failure as a cause of pulmonary hypertension. , 1994, Internal medicine.
[30] J. Stamler,et al. Nitric oxide regulates basal systemic and pulmonary vascular resistance in healthy humans. , 1994, Circulation.
[31] D. Stewart,et al. Expression of endothelin-1 in the lungs of patients with pulmonary hypertension. , 1993, The New England journal of medicine.
[32] E H Bergofsky,et al. Survival in Patients with Primary Pulmonary Hypertension: Results from a National Prospective Registry , 1991 .
[33] D. Stewart,et al. Increased plasma endothelin-1 in pulmonary hypertension: marker or mediator of disease? , 1991, Annals of internal medicine.
[34] H Ihlen,et al. Cardiac stroke volume during exercise measured by Doppler echocardiography: comparison with the thermodilution technique and evaluation of reproducibility. , 1987, British heart journal.
[35] D. Buff. Primary pulmonary hypertension. , 1987, Annals of internal medicine.
[36] M. Yacoub,et al. The pathology of the early and late stages of primary pulmonary hypertension. , 1987, British heart journal.
[37] J. Conger,et al. Pulmonary calcification in chronic dialysis patients. Clinical and pathologic studies. , 1975, Annals of internal medicine.
[38] T. Rabelink,et al. Endothelial function and the kidney. An emerging target for cardiovascular therapy. , 1997, Drugs.
[39] W. Markiewicz,et al. Septal/free wall curvature ratio: a noninvasive index of pulmonary arterial pressure. , 1994, Journal of the American Society of Echocardiography : official publication of the American Society of Echocardiography.